Ledger.Open graph →

SEC Form D · Amendment · filed July 24, 2024

Medcura, Inc

Offering

$22.8M

Sold

$22.5M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

RIVERDALE, MD

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Jim Buck · Riverdale, MDExec · Director Matthew Dowling, Ph.D · Riverdale, MDExec · Director Larry Tiffany · Riverdale, MDExec · Director Rich Vincent · Riverdale, MDExec Abbas Ardehali, M.D · Riverdale, MDDirector Matthew Dowling, Ph.D · Riverdale, MDExec · Director Rich Vincent · Riverdale, MDExec Larry Tiffany · Riverdale, MDExec · Director Jim Buck · Riverdale, MDExec · Director Abbas Ardehali, M.D · Riverdale, MDDirector Ivana Faltysova · Grand Cayman, Cayman IslandsDirector Ray Mayo · Greenwich, CTExec · Director Eliezer Brender · New York, NYExec · Director John Rieck · Keswick, VAExec Encompass Capital Partners LLC · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗